Showing 1-10 of about 106 articles.
International Society for Heart & Lung Transplantation
ORLANDO, Fla., April 05, 2019 (GLOBE NEWSWIRE) -- An approach to organ recovery based on military-style Special Ops teams leads to better outcomes for both patients and hospitals, according to a...
International Society for Heart & Lung Transplantation
Orlando, Fla., April 04, 2019 (GLOBE NEWSWIRE) -- A growing body of research suggests that heart transplantation from donors with active Hepatitis C (HCV) is safe – and that the virus successfully...
International Society for Heart & Lung Transplantation
Orlando, Fla., April 04, 2019 (GLOBE NEWSWIRE) -- While marijuana laws differ from state-to-state, researchers are calling for uniform guidelines for marijuana use and transplant organ eligibility. ...
International Society for Heart & Lung Transplantation
Orlando, Florida, April 03, 2019 (GLOBE NEWSWIRE) -- The Journal of Heart and Lung Transplantation is releasing its themed issue on Mechanical Circulatory Support to coincide with the 39th Annual...
International Society for Heart & Lung Transplantation
Orlando, Florida, April 03, 2019 (GLOBE NEWSWIRE) -- A common heart pump has traditionally been seen as only a short-term option for heart-failure patients but new research shows it may provide a...
SANUWAVE Health, Inc.
SUWANEE, GA, April 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of...
ARCA biopharma, Inc.
WESTMINSTER, Colo., March 18, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Royal Philips
March 17, 2019 Nearly one in four patients in the study treated with standard of care percutaneous coronary intervention (PCI) had residual ischemia after coronary stent implantation intended to...
ARCA biopharma, Inc.
WESTMINSTER, Colo., March 06, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
ARCA biopharma, Inc.
WESTMINSTER, Colo., Feb. 27, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Showing 1-10 of about 106 articles.
